General information

Full name                               
European Infrastructure for Translational Medicin
Short nameEATRIS
Legal statusERIC
Operational statusfully operational
 
Coordinating institutionEATRIS-ERIC
Operations & Finance Director
Anton Ussi
  
RI member countries
CZ, EE, ES, FI, FR, IT, LU, LV, NL, NO, SI, SE                  
Observer-
 
Websitewww.eatris.eu
ContactAnton Ussi
antonussi [at] eatris.eu

National nodes

This sections provides an overview on the national subsidiaries of the RI.

NameWebsite, contact
Finland

Contact: Andreas Scherer, andreasscherer [at] eatris.eu

Website 

SwedenContact: Ulrika Backman,  ulrikabackman [at] eatris.eu
Website

Description of the organisation

EATRIS is the European infrastructure for translational medicine, providing high quality services in early development of novel therapeutics and diagnostics. Translational research is defined as research that develops promising biomedical innovations 'from bench to bedside,' and conversely brings clinical insights from bedside back to bench.
EATRIS strives to accelerate medicines and diagnostics development by utilising cutting-edge, enabling technologies in early translational research. Academic researchers, companies and charities can access clinical expertise and high-end facilities that are available within the 80 top-tier academic centres across Europe comprising EATRIS.

EATRIS focuses on preclinical and early clinical development of drugs, vaccines and diagnostics. Solutions are provided in the fields of advanced therapy medicinal products, biomarkers, imaging and tracing, small molecules and vaccines.
The wide-ranging services portfolio focuses on supporting early decision-making and de-risking of projects. Examples include validation and development of in vitro and in vivo biomarkers for patient stratification, molecular imaging tracers for drug development programmes, GMP manufacturing of cellular therapy products, patient-derived xenograft models, and many more highly specialised capabilities. Biomedical inventions frequently fail to pass the valley of death for various reasons. EATRIS aims to overcome translational challenges by (1) development of new enabling technologies within the consortium, and (2) make high quality services available for other researchers.
Translational research is a highly multi-disciplinary and complex undertaking. As a consequence, a major challenge in developing new innovations is understanding what steps need to be taken, and what expertise and technologies are suitable to perform these steps. External researchers in need for academic support will find that EATRIS is able to provide guidance in next steps to be taken, by means of clinical and technological expertise available within the infrastructure. Subsequently, EATRIS will match the need with the capabilities within the infrastructure. In this way EATRIS facilitates collaboration among academics and between academics and companies.

EATRIS is a non-profit European Research Infrastructure Consortium (ERIC). Member institutions are selected on the basis of their track record in public-private collaboration in translational development and their multidisciplinary teams of leading academic experts, high-end research facilities, production laboratories and licenses.

Service offer

A list of services offered by EATRIS can be downloaded here.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This project receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 654248.